武汉大学中南医院循证与医学转化中心

导航
首页 > 成果展示 > 正文

Plasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis

发布于2015-07-11 10:20:53    人阅读
 2015 Jul 9;5:12002. doi: 10.1038/srep12002.

Abstract

The aim of this study was to compare plasmakinetic resection of the prostate (PKRP) with transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) in terms of efficacy and safety. Published RCTs were searched from PubMed, Embase, Science Citation Index, and Cochrane Library up to April 10, 2014. After methodological quality assessment and data extraction, meta-analysis was performed using the STATA 12.0 software. 18 reports of 16 RCTs were included in this analysis. Meta-analyses showed that PKRP significantly improved Qmax at 12 months, but no significant difference was found for other efficacy outcomes. In terms of safety, treatment of PKRP was associated with reduced drop in serum sodium, lower TUR syndrome, reduced need of blood transfusion, clot retention, and shorter catheterization time and hospital stay; in contrast, there were no significant differences in the analysis of operative time, postoperative fever, and long-term postoperative complications. In summary, current evidence suggests that, although PKRP and TURP are both effective for BPH, PKRP is associated with additional potential benefits in efficacy and more favorable safety profile. It may be possible that PKRP may replace the TURP in the future and become a new standard surgical procedure.

PMID: 26156138 [PubMed - in process]

作者团队:李胜,Kwong JS,曾宪涛,翁鸿,孟祥喻,郭毅,徐畅,刘同族,王行环*,
等.


PUBMED网址链接:http://www.ncbi.nlm.nih.gov/pubmed/26156138

中科院分区: 2 区

版权所有:武汉大学中南医院循证与转化医学中心
技术支持:西安渔夫网络科技有限公司
联系我们

湖北省武汉市武昌区,东湖路169号    邮编:430071

电话/传真:+86 027 67812817    邮箱:zhongnan@163.com    微博:http://weibo.com/whuznyy